Matthew McClure, MD

Lifordi
Burlington, Massachusetts, United States

Chief Medical Officer responsible for developing immunotherapeutics, including antibody drug conjugates

Presentation(s):

• 0494: LFD-200, an Antibody Drug Conjugate that Selectively Delivers a Glucocorticoid Payload to Immune Cells, Provides Sustained Anti-inflammatory Effects Without Systemic Toxicity in Non-human Primates

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): Lifordi Immunotherapeutics: Employee (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)